C4 Therapeutics (CCCC) Other Non Operating Income (2019 - 2023)

C4 Therapeutics' Other Non Operating Income history runs 3 years deep, the most recent figure standing at -$621000.0 for Q3 2023.

• On a quarterly basis, Other Non Operating Income changed N/A year-over-year to -$621000.0 in Q3 2023; TTM through Dec 2024 was -$621000.0, a 0.0% change from a year earlier, with the FY2023 full-year figure at -$621000.0, changed N/A from the prior year.
• Other Non Operating Income retreated to -$621000.0 in Q3 2023 per CCCC's latest filing, from $43000.0 in the prior quarter.
• Across five years, Other Non Operating Income topped out at $43000.0 in Q3 2020 and bottomed at -$621000.0 in Q3 2023.
• The 3-year median for Other Non Operating Income is -$1000.0 (2019), against an average of -$193000.0.
• Biggest YoY gain for Other Non Operating Income was 4400.0% in 2020; the steepest drop was 4400.0% in 2020.
• Year by year, Other Non Operating Income stood at -$1000.0 in 2019, then surged by 4400.0% to $43000.0 in 2020, then sank by 1544.19% to -$621000.0 in 2023.
• Per Business Quant, the three latest CCCC Other Non Operating Income figures stand at -$621000.0 (Q3 2023), $43000.0 (Q3 2020), and -$1000.0 (Q3 2019).